Elizabeth Cermak
Patrimonio netto: - $ in data 30/06/2026
Patrimonio netto: - $ in data 30/06/2026
Elizabeth A. Cermak is currently an Independent Director at Moleculin Biotech, Inc. since 2020.
Former positions include Independent Director at Clarus Therapeutics, Inc., Director at SteadyMed Therapeutics, Inc. from 2015 to 2018, External Director at SteadyMed Ltd. from 2015 to 2018, Independent Director at QUE Oncology, Inc., Director at Ocean Ridge Charities Association, Inc., Director at Neurana Pharmaceuticals, Inc., Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022, Vice President-Professional Sales & Marketing at Johnson & Johnson, Chief Commercial Officer & Executive VP at POZEN, Inc. from 2009 to 2013, and Vice President-Business Development at McNeil Consumer & Specialty Pharmaceuticals, Inc. Education includes undergraduate studies at Franklin & Marshall College and an MBA from Lebow College of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Direttore/Membro del Consiglio | 02/10/2020 |
| Società | Posizione | Fine |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Direttore/Membro del Consiglio | 31/10/2022 |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops drug delivery therapeutics devices | Direttore/Membro del Consiglio | 01/09/2018 |
| STEADYMED LTD | Direttore/Membro del Consiglio | 30/08/2018 |
| POZEN INC. | Corporate Officer/Principal | 01/01/2013 |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Johnson & Johnson
Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
POZEN, Inc.
POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
Franklin & Marshall College
Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McNeil Consumer & Specialty Pharmaceuticals, Inc.
McNeil Consumer & Specialty Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pain relievers | Health Technology |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops drug delivery therapeutics devices | Health Services |
Lebow College of Business
Lebow College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in focused on preventing and treating life-threatening cancers and related conditions | Health Technology |
Ocean Ridge Charities Association, Inc. | |
Moleculin Biotech, Inc.
Moleculin Biotech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of treatments for highly resistant cancers and viruses | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale